top of page
  • CGA-IGC

#WorldCancerDay: CGA-IGC's focus to "Close the care gap"

Updated: Mar 7


#WorldCancerDay2023 marks the second year of the campaign “Close the care gap” to reduce the inequities that exist in accessing quality cancer services worldwide.


It was back in 2020 when CGA-IGC shared its commitment to diversity, equity, and inclusion with the community to address the inequities in its own field.


The Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA-IGC) promotes diversity and inclusiveness throughout the organization including in its membership, governance, and education programming. The CGA-IGC also recognizes the importance of advancing health equity in patient care in achieving our core mission as an organization. Read the full statement here

The CGA-IGC leadership then took the step to create a Diversity & Equity Committee, which was tasked to implement the statement’s commitments through cross-collaboration with the existing CGA-IGC committees.


Some of these collaborations resulted in resources that are now available in the form of the LGBTQ+ toolkit which aggregates various CGA-IGC resources or those from other stakeholders with the aim to support the needs and interests of the multidisciplinary #HereditaryGICancer community.


Our annual meetings through its Advancing Health Equity Abstract Presentations address key issues affecting minority communities such as:

The 2021 Lemuel Herrera Lectureship, presented by John M. Carethers, MD, MACP, addressed Increasing Diversity in Academic Medicine and Overcoming Colorectal Cancer Screening Barriers.

Sign up as a CGA-IGC member to access these presentations on demand!

Since the 1980s, the incidence of colorectal cancer (CRC) in adults under age 50 has increased in the US and other western countries. Currently, patients with early-onset colorectal cancer (eoCRC) are managed according to guidelines that are not age-specific, which could be why there is an increase in CRC-related mortality among younger patients during the past decade.


Thus, the global #HereditaryGICancer community decided to address this issue by convening a multidisciplinary international group to develop the first evidence-based consensus recommendations for eoCRC. CGA-IGC is now a key partner in the Delphi Initiative Recommendations on Early-Onset Colorectal Cancer International Management Guidelines, with many of the 69 experts being CGA-IGC members and playing a key role in the development of these guidelines.


On the occasion of #ColorectalCancerAwarenessMonth, CGA-IGC will launch another toolkit and aggregate important resources related to eoCRC. Keepan eye out for a special interview with Drs. Swati Patel, Giulia Martina Cavestro, Marta Puzzono, and Alessandro Mannucci where they discuss in more detail the initiative, why it was needed, and how it was developed, including some of the key findings and how these guidelines can help in clinical care, and much more! An interview not to be missed!


In 2022, under the leadership of Dr. Swati Patel, CGA-IGC announced a new initiative: the CGA-IGC Ambassador Program. This exciting initiative aims to strengthen relationships, promote collaborations, and share resources between international organizations active in the #HereditaryGICancer field. To help move this effort forward, the CGA-IGC Executive Council has nominated Prof. Mev Dominguez-Valentin, PhD to serve as the inaugural CGA-IGC Ambassador to the European Hereditary Tumor Group (EHTG) and the Latin America Group of the Hereditary Tumors (LA-GETH).


The creation of the DIRECt International Management Guidelines highlighted the need for global collaboration in order to better address the needs of patients with #HereditaryGICancer and it is hoped that the CGA-IGC Ambassador Program will help facilitate collaborations addressing other inequities faced by the global #HereditaryGICancer community and go some way to #CloseTheCareGap.

13 views0 comments